Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 November 2022 | Story Anthony Mthembu | Photo Barend Nagel
Siphilangenkosi Dlamini
Siphilangenkosi Dlamini – selected by Inside Education and the NYDA as one of South Africa’s 100 Shining Stars for 2022.

Siphilangenkosi Dlamini, a fourth-year Governance and Political Transformation student at the University of the Free State (UFS), has been selected as one of South Africa’s 100 Shining Stars for 2022 by Inside Education, in partnership with the National Youth Development Agency (NYDA). 

“I was more surprised than anything, but also very honoured,” he said. Dlamini, who made it into the Civil Society and Youth category, was chosen from a pool of 800 applicants for his remarkable work with the Help a Student initiative, and his services as the former secretary of the Southern Africa Scout Youth Forum. Although he could not attend the award ceremony held in Johannesburg on 20 October 2022 in person, Dlamini did receive a certificate. “What we do a lot of the time isn’t for recognition and it’s not necessarily for awards; but getting recognised motivates and assures me that the work we are doing has an impact,” he expressed.

The Help a Student Initiative

In the early stages of the COVID-19 pandemic, Dlamini recognised a rise in food insecurity among his fellow students. This set him on a path to source funding for the establishment of the project. 

The Help a Student initiative aimed to curb food insecurity through the provision of food parcels to UFS students who were in need. The project, which ran from 2020 until early 2021, managed to distribute food parcels to nearly 250 students per month. The initiative did not only assist students who were on campus. The selected applicants who were at home or off campus also received digital food vouchers, which allowed for the purchasing of food items at Pick n Pay and/or Shoprite.

“Food security is something that I am passionate about. I grew up in a community where it was a massive issue.

However, in the past I was not empowered enough to know how to solve it. Therefore, when the opportunity presented itself to do something about it, I took it with both hands,” Dlamini expressed.

Although the recognition was not expected, Dlamini maintains that such platforms are imperative, as “they demonstrate that young people are doing something to improve the country in the different capacities they are in”.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept